These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 26811406

  • 1. Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency.
    Schulz J, Frey KR, Cooper MS, Zopf K, Ventz M, Diederich S, Quinkler M.
    Eur J Endocrinol; 2016 Apr; 174(4):531-8. PubMed ID: 26811406
    [Abstract] [Full Text] [Related]

  • 2. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
    Koetz KR, Ventz M, Diederich S, Quinkler M.
    J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966
    [Abstract] [Full Text] [Related]

  • 3. [Estimation of influence of congenital-adrenal hyperplasia treatment on bone mineralisation evaluated with densitometry].
    Romanowska H, Krzywińska-Zdeb E, Giżewska M, Kotkowiak L, Safranow K, Horodnicka-Józwa A, Petriczko E, Krupa B, Walczak M.
    Pediatr Endocrinol Diabetes Metab; 2012 Jan; 18(1):21-6. PubMed ID: 22525687
    [Abstract] [Full Text] [Related]

  • 4. BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy.
    Koetz KR, van Rossum EF, Ventz M, Diederich S, Quinkler M.
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):831-7. PubMed ID: 23134110
    [Abstract] [Full Text] [Related]

  • 5. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia.
    Falhammar H, Filipsson Nyström H, Wedell A, Brismar K, Thorén M.
    Eur J Endocrinol; 2013 Mar; 168(3):331-41. PubMed ID: 23211577
    [Abstract] [Full Text] [Related]

  • 6. Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia.
    Ganesh R, Suresh N, Janakiraman L, Ravikumar K.
    Indian J Pediatr; 2016 Feb; 83(2):126-30. PubMed ID: 26223873
    [Abstract] [Full Text] [Related]

  • 7. Increased serum osteoprotegerin in patients with primary adrenal insufficiency receiving conventional hydrocortisone substitution.
    Fichna M, Zurawek M, Fichna P, Gryczynska M, Nowak J, Ruchala M.
    J Physiol Pharmacol; 2012 Dec; 63(6):677-82. PubMed ID: 23388484
    [Abstract] [Full Text] [Related]

  • 8. Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Ceccato F, Barbot M, Albiger N, Zilio M, De Toni P, Luisetto G, Zaninotto M, Greggio NA, Boscaro M, Scaroni C, Camozzi V.
    Eur J Endocrinol; 2016 Aug; 175(2):101-6. PubMed ID: 27185866
    [Abstract] [Full Text] [Related]

  • 9. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.
    Guo CY, Weetman AP, Eastell R.
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):535-41. PubMed ID: 8977749
    [Abstract] [Full Text] [Related]

  • 10. The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia.
    Cetinkaya S, Kara C.
    J Pediatr Endocrinol Metab; 2011 Nov; 24(5-6):265-9. PubMed ID: 21823521
    [Abstract] [Full Text] [Related]

  • 11. [Introduction: Patients with primary adrenal insufficiency receive long - term glucocorticoid replacement therapy, which may cause osteoporosis].
    Vaňuga P, Ságová I.
    Vnitr Lek; 2021 Nov; 67(5):264-269. PubMed ID: 35459392
    [Abstract] [Full Text] [Related]

  • 12. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency.
    Sciannamblo M, Russo G, Cuccato D, Chiumello G, Mora S.
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4453-8. PubMed ID: 16926248
    [Abstract] [Full Text] [Related]

  • 13. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue.
    Halper A, Sanchez B, Hodges JS, Dengel DR, Petryk A, Sarafoglou K.
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):124-130. PubMed ID: 31070802
    [Abstract] [Full Text] [Related]

  • 14. Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy.
    Zimmermann A, Sido PG, Schulze E, Al Khzouz C, Lazea C, Coldea C, Weber MM.
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):477-84. PubMed ID: 19170706
    [Abstract] [Full Text] [Related]

  • 15. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone.
    Løvås K, Gjesdal CG, Christensen M, Wolff AB, Almås B, Svartberg J, Fougner KJ, Syversen U, Bollerslev J, Falch JA, Hunt PJ, Chatterjee VK, Husebye ES.
    Eur J Endocrinol; 2009 Jun; 160(6):993-1002. PubMed ID: 19282465
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Bachelot A, Plu-Bureau G, Thibaud E, Laborde K, Pinto G, Samara D, Nihoul-Fékété C, Kuttenn F, Polak M, Touraine P.
    Horm Res; 2007 Jun; 67(6):268-76. PubMed ID: 17170529
    [Abstract] [Full Text] [Related]

  • 17. Bone mineral density and body composition in congenital adrenal hyperplasia.
    Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL, Wark JD.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
    [Abstract] [Full Text] [Related]

  • 18. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia.
    Girgis R, Winter JS.
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3926-9. PubMed ID: 9398689
    [Abstract] [Full Text] [Related]

  • 19. Changes in bone mineral density following discontinuation or continuation of alendronate therapy in glucocorticoid-treated patients: a retrospective, observational study.
    Emkey R, Delmas PD, Goemaere S, Liberman UA, Poubelle PE, Daifotis AG, Verbruggen N, Lombardi A, Czachur M.
    Arthritis Rheum; 2003 Apr; 48(4):1102-8. PubMed ID: 12687554
    [Abstract] [Full Text] [Related]

  • 20. Bone Mass in Young Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
    Espinosa Reyes TM, Leyva González G, Domínguez Alonso E, Falhammar H.
    Horm Res Paediatr; 2021 Apr; 94(1-2):1-8. PubMed ID: 34044395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.